Cresco closes $50 million acquisition of nine Pennsylvania dispensaries

Cresco Labs closed its $50 million purchase of PharmaCann Penn, adding nine medical dispensaries and claiming the leading retail and wholesale position in Pennsylvania. For Oklahoma operators, the deal is a concrete consolidation and capital-allocation signal from a large multistate company operating in a maturing medical market.